Table of Contents

company-logo

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

PYC Therapeutics Dividend Announcement

• PYC Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on PYC Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

PYC Therapeutics Dividend History

PYC Therapeutics Dividend Yield

PYC Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing PYC Therapeutics stock? Use our calculator to estimate your expected dividend yield:

PYC Therapeutics Financial Ratios

P/E ratio-200.46
PEG ratio-2.03
P/B ratio93.95
ROE-68.34%
Payout ratio0.00%
Current ratio9.40
Quick ratio9.40
Cash Ratio7.34

PYC Therapeutics Dividend FAQ

Does PYC Therapeutics stock pay dividends?
PYC Therapeutics does not currently pay dividends to its shareholders.
Has PYC Therapeutics ever paid a dividend?
No, PYC Therapeutics has no a history of paying dividends to its shareholders. PYC Therapeutics is not known for its dividend payments.
Why doesn't PYC Therapeutics pay dividends?
There are several potential reasons why PYC Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will PYC Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While PYC Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is PYC Therapeutics a dividend aristocrat?
PYC Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is PYC Therapeutics a dividend king?
PYC Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is PYC Therapeutics a dividend stock?
No, PYC Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy PYC Therapeutics stocks?
To buy PYC Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy PYC Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.